France stands as a prominent player in the life sciences and healthcare sector within Europe. It holds a significant position in the global pharmaceutical market, ranking fifth in terms of market value. France’s public and private healthcare spending accounts for 11.2 per cent of GDP, the highest among European Union countries, surpassing the Netherlands (9.9 per cent) and the UK (9.8 per cent). In terms of employment, France ranks second in the pharmaceutical sector (after Germany) and fourth in the medtech sector, following Germany, Italy, and the UK.
France – Lyon
Table of Contents
More from Life Sciences Real Estate